ALDX
Price
$6.69
Change
-$0.03 (-0.45%)
Updated
Feb 21 closing price
Capitalization
398.39M
11 days until earnings call
VNDA
Price
$4.43
Change
-$0.06 (-1.34%)
Updated
Feb 21 closing price
Capitalization
258.34M
66 days until earnings call
Ad is loading...

ALDX vs VNDA

Header iconALDX vs VNDA Comparison
Open Charts ALDX vs VNDABanner chart's image
Aldeyra Therapeutics
Price$6.69
Change-$0.03 (-0.45%)
Volume$370.46K
Capitalization398.39M
Vanda Pharmaceuticals
Price$4.43
Change-$0.06 (-1.34%)
Volume$569.32K
Capitalization258.34M
ALDX vs VNDA Comparison Chart
Loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALDX vs. VNDA commentary
Feb 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALDX is a StrongBuy and VNDA is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 24, 2025
Stock price -- (ALDX: $6.61 vs. VNDA: $4.46)
Brand notoriety: ALDX and VNDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALDX: 149% vs. VNDA: 138%
Market capitalization -- ALDX: $398.39M vs. VNDA: $258.34M
ALDX [@Biotechnology] is valued at $398.39M. VNDA’s [@Biotechnology] market capitalization is $258.34M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.43B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALDX’s FA Score shows that 0 FA rating(s) are green whileVNDA’s FA Score has 1 green FA rating(s).

  • ALDX’s FA Score: 0 green, 5 red.
  • VNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, both ALDX and VNDA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALDX’s TA Score shows that 6 TA indicator(s) are bullish while VNDA’s TA Score has 3 bullish TA indicator(s).

  • ALDX’s TA Score: 6 bullish, 4 bearish.
  • VNDA’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ALDX is a better buy in the short-term than VNDA.

Price Growth

ALDX (@Biotechnology) experienced а +11.37% price change this week, while VNDA (@Biotechnology) price change was -5.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.27%. For the same industry, the average monthly price growth was +3.99%, and the average quarterly price growth was +2.35%.

Reported Earning Dates

ALDX is expected to report earnings on May 01, 2025.

VNDA is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Biotechnology (+4.27% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ALDX($398M) has a higher market cap than VNDA($258M). ALDX YTD gains are higher at: 34.068 vs. VNDA (-6.889). VNDA has higher annual earnings (EBITDA): -30.16M vs. ALDX (-42.57M). VNDA has more cash in the bank: 376M vs. ALDX (113M). VNDA has less debt than ALDX: VNDA (7.94M) vs ALDX (15.6M). VNDA has higher revenues than ALDX: VNDA (191M) vs ALDX (0).
ALDXVNDAALDX / VNDA
Capitalization398M258M154%
EBITDA-42.57M-30.16M141%
Gain YTD34.068-6.889-495%
P/E RatioN/A137.00-
Revenue0191M-
Total Cash113M376M30%
Total Debt15.6M7.94M196%
FUNDAMENTALS RATINGS
ALDX vs VNDA: Fundamental Ratings
ALDX
VNDA
OUTLOOK RATING
1..100
265
VALUATION
overvalued / fair valued / undervalued
1..100
51
Fair valued
84
Overvalued
PROFIT vs RISK RATING
1..100
95100
SMR RATING
1..100
9791
PRICE GROWTH RATING
1..100
3760
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALDX's Valuation (51) in the Biotechnology industry is somewhat better than the same rating for VNDA (84). This means that ALDX’s stock grew somewhat faster than VNDA’s over the last 12 months.

ALDX's Profit vs Risk Rating (95) in the Biotechnology industry is in the same range as VNDA (100). This means that ALDX’s stock grew similarly to VNDA’s over the last 12 months.

VNDA's SMR Rating (91) in the Biotechnology industry is in the same range as ALDX (97). This means that VNDA’s stock grew similarly to ALDX’s over the last 12 months.

ALDX's Price Growth Rating (37) in the Biotechnology industry is in the same range as VNDA (60). This means that ALDX’s stock grew similarly to VNDA’s over the last 12 months.

VNDA's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for ALDX (100). This means that VNDA’s stock grew significantly faster than ALDX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALDXVNDA
RSI
ODDS (%)
Bearish Trend 6 days ago
84%
N/A
Stochastic
ODDS (%)
Bearish Trend 6 days ago
85%
Bearish Trend 6 days ago
76%
Momentum
ODDS (%)
Bullish Trend 6 days ago
90%
Bullish Trend 6 days ago
72%
MACD
ODDS (%)
Bullish Trend 6 days ago
90%
Bullish Trend 6 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 6 days ago
86%
Bearish Trend 6 days ago
74%
TrendMonth
ODDS (%)
Bullish Trend 6 days ago
87%
Bullish Trend 6 days ago
73%
Advances
ODDS (%)
Bullish Trend 6 days ago
84%
Bullish Trend 17 days ago
68%
Declines
ODDS (%)
Bearish Trend 21 days ago
79%
Bearish Trend 10 days ago
71%
BollingerBands
ODDS (%)
Bearish Trend 6 days ago
81%
Bearish Trend 6 days ago
78%
Aroon
ODDS (%)
Bullish Trend 6 days ago
87%
Bearish Trend 6 days ago
75%
View a ticker or compare two or three
Ad is loading...
ALDX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

ALDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALDX has been loosely correlated with GSGTF. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if ALDX jumps, then GSGTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALDX
1D Price
Change %
ALDX100%
-0.45%
GSGTF - ALDX
56%
Loosely correlated
N/A
FOLD - ALDX
43%
Loosely correlated
+1.32%
ROIV - ALDX
41%
Loosely correlated
-0.37%
IOVA - ALDX
41%
Loosely correlated
+3.03%
ABSI - ALDX
40%
Loosely correlated
-4.43%
More

VNDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VNDA has been loosely correlated with IKNA. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if VNDA jumps, then IKNA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNDA
1D Price
Change %
VNDA100%
+0.90%
IKNA - VNDA
37%
Loosely correlated
-0.67%
SNGX - VNDA
32%
Poorly correlated
+2.09%
ATRA - VNDA
30%
Poorly correlated
-5.94%
ALDX - VNDA
29%
Poorly correlated
+1.85%
CLDX - VNDA
29%
Poorly correlated
-0.70%
More